Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berenbaum

Showing results (731-740 of 805) with videos related to

Pageof 81
Sort By:
Nature Communications|November 5, 2025
Safety and immunogenicity of PPV-06, an active anti-IL-6 immunotherapy targeting low-grade inflammation against knee osteoarthritis: a randomized, double-blind, placebo-controlled, clinical phase 1 studyFrançois Rannou, Lucille Desallais, Christelle Nguyen, et al.
Joint Bone Spine|October 2, 2007
The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patientsBernard Combe, Joëlle Benessiano, Francis Berenbaum, et al.
Osteoarthritis and Cartilage|December 16, 2019
Development of a core capability framework for qualified health professionals to optimise care for people with osteoarthritis: an OARSI initiativeR S Hinman, K D Allen, K L Bennell, et al.
Insect Molecular Biology|June 22, 2010
Decreased detoxification genes and genome size make the human body louse an efficient model to study xenobiotic metabolismS H Lee, J S Kang, J S Min, et al.
Osteoarthritis and Cartilage|July 14, 2020
Identification of TGFβ signatures in six murine models mimicking different osteoarthritis clinical phenotypesM Maumus, D Noël, H K Ea, et al.
Journal of Autoimmunity|February 8, 2024
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trialRoberta Lorenzon, Claire Ribet, Fabien Pitoiset, et al.
Seminars in Arthritis and Rheumatism|September 20, 2021
Core outcome measurement instrument selection for physical function in hand osteoarthritis using the OMERACT Filter 2.1 processFéline P B Kroon, Désirée van der Heijde, Lara J Maxwell, et al.
The Journal of Rheumatology|August 17, 2013
Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohortBernard Combe, Nathalie Rincheval, Joelle Benessiano, et al.
Annals of the Rheumatic Diseases|December 16, 2018
Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritisMargreet Kloppenburg, Charles Peterfy, Ida K Haugen, et al.
Frontiers in Psychiatry|February 9, 2026
Engagement, efficacy, and experiences of psychotherapy for perinatal populations with depression and anxiety during the COVID-19 pandemicHolly A Krohn, Sandeep Shelly, Jamie E Gibori, et al.
Pageof 81

Showing results (731-740 of 805) with videos related to

Sort By:
Pageof 81
Nature Communications|November 5, 2025
Safety and immunogenicity of PPV-06, an active anti-IL-6 immunotherapy targeting low-grade inflammation against knee osteoarthritis: a randomized, double-blind, placebo-controlled, clinical phase 1 studyFrançois Rannou, Lucille Desallais, Christelle Nguyen, et al.
Joint Bone Spine|October 2, 2007
The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patientsBernard Combe, Joëlle Benessiano, Francis Berenbaum, et al.
Osteoarthritis and Cartilage|December 16, 2019
Development of a core capability framework for qualified health professionals to optimise care for people with osteoarthritis: an OARSI initiativeR S Hinman, K D Allen, K L Bennell, et al.
Insect Molecular Biology|June 22, 2010
Decreased detoxification genes and genome size make the human body louse an efficient model to study xenobiotic metabolismS H Lee, J S Kang, J S Min, et al.
Osteoarthritis and Cartilage|July 14, 2020
Identification of TGFβ signatures in six murine models mimicking different osteoarthritis clinical phenotypesM Maumus, D Noël, H K Ea, et al.
Journal of Autoimmunity|February 8, 2024
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trialRoberta Lorenzon, Claire Ribet, Fabien Pitoiset, et al.
Seminars in Arthritis and Rheumatism|September 20, 2021
Core outcome measurement instrument selection for physical function in hand osteoarthritis using the OMERACT Filter 2.1 processFéline P B Kroon, Désirée van der Heijde, Lara J Maxwell, et al.
The Journal of Rheumatology|August 17, 2013
Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohortBernard Combe, Nathalie Rincheval, Joelle Benessiano, et al.
Annals of the Rheumatic Diseases|December 16, 2018
Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritisMargreet Kloppenburg, Charles Peterfy, Ida K Haugen, et al.
Frontiers in Psychiatry|February 9, 2026
Engagement, efficacy, and experiences of psychotherapy for perinatal populations with depression and anxiety during the COVID-19 pandemicHolly A Krohn, Sandeep Shelly, Jamie E Gibori, et al.
Pageof 81